Delivery Order SPE2DB24D1021-SPE2DB25FFASC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Sunosi 150 mg tablets (30-count packaging) valued at $1,013.56. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion master agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on July 17, 2025, for the supply of Sunosi 75 mg tablets (30-count units) with a ceiling value of $4,264.03. This non-set-aside contract represents a firm fixed price delivery order and is part of AmerisourceBergen's broader engagement with DLA's medical supply chain. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 18,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Sunosi 150 mg tablets (30-count units) at a firm fixed price totaling $1,345.47. This non-set-aside contract is a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. The delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,141.29 to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Sunosi 150 mg tablets in a quantity of 30 units. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The contract is scheduled for ultimate completion on July 9, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,154.87 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sunosi 150 mg tablets (30-count units). This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 13, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $2,445.76 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Sunosi 150 mg tablets (30-count). This firm fixed-price contract represents a non-set-aside competitive award and is scheduled for completion by September 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- AmerisourceBergen Drug Corp received a delivery order valued at $4,627.82 from the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Sunosi 75 mg tablets (30-count units). This firm fixed-price contract, which is non-set-aside and competitively awarded, is scheduled for completion by July 23, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,792.60 to AmerisourceBergen Drug Corp for the supply of Sunosi (solriamfetol) 75 mg tablets in a 30-count package. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, and the place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,842.01 to AmerisourceBergen Drug Corp for the supply of Sunosi 150 mg tablets (30-count units) on September 10, 2025, with completion targeted for September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $1,089.60 to AmerisourceBergen Drug Corp for the supply of Sunosi 150 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract represents a direct procurement action under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFASCDelivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for 30 tablets of Sunosi 150 mg, a medication used to treat excessive daytime sleepiness. This competitive, firm fixed-price delivery order was awarded on September 15, 2025, with a ceiling value of $1,345.47 and an ultimate completion date of September 16, 2025. The contract carries no set-aside designation and represents a small-value transaction under the company's larger federal pharmaceutical supply framework. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other federal agencies. The DLA Medical Supply Chain leverages this arrangement to procure critical pharmaceutical products across multiple therapeutic domains, enabling efficient distribution of medical commodities to Defense Health Agency, U.S. Coast Guard, and other government healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/15/25 |